American Law News – Fenwick Represents Treeline Biosciences in Definitive Merger Agreement with Standard BioTools
Fenwick is representing Treeline Biosciences, a clinical-stage biopharma company that aspires to make medicines at the highest level, in its definitive merger agreement with Standard BioTools Inc. (Nasdaq: LAB). The combined company will operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders, and targeted therapy antibody-drug conjugates. The proposed transaction





